(Total Views: 688)
Posted On: 03/24/2021 2:41:52 PM
Post# of 154883
Article Posted Yesterday
Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab
This person had been on extracorporeal membrane oxygenation (ECMO) for an extended period of time before receiving 4 doses of leronlimab. The male subject received his first dose of leronlimab on Day 79 of hospitalization he was weaned off ECMO by Day 84 and discharged from the ECMO intensive care unit on Day 91. He continues to improve and is currently in rehabilitation.
https://www.sciencedirect.com/science/article...rss_sd_all
Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab
This person had been on extracorporeal membrane oxygenation (ECMO) for an extended period of time before receiving 4 doses of leronlimab. The male subject received his first dose of leronlimab on Day 79 of hospitalization he was weaned off ECMO by Day 84 and discharged from the ECMO intensive care unit on Day 91. He continues to improve and is currently in rehabilitation.
https://www.sciencedirect.com/science/article...rss_sd_all
(8)
(0)
